The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients Who Are Poor Responders to Induction: The Mayo Clinic ExperienceIuliana Vaxman, Morie A. Gertz, Shaji Kumar et al.|Transplantation and Cellular Therapy|2021Cited by 14
Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplantAbdullah S. Al Saleh, Morie A. Gertz, M Hasib Sidiqi et al.|Bone Marrow Transplantation|2020Cited by 13